StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen defined Contribution Employee Benefit Plans — Total Company Expense (10-K) ($M) ($M)

Form 10-K Employee Benefit Plans Note & Form 11-K U.S. / Puerto Rico Annual Reports

Latest, FY2025
407
Period ended Dec 31, 2025
Change on a year earlier
+8.5%
375 in FY2024
History
10 years
Since FY2016
Sources
7
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDefined Contribution Employee Benefit Plans — Total Company Expense (10-K) ($M) ($M)Year on yearSource
FY2025Dec 31, 2025407+8.5%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 2024375+20.6%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 2023311+28.0%Form 10-K (filed 2026-02-13) ↗
FY2022Dec 31, 2022243-12.9%Form 10-K (filed 2025-02-14) ↗
FY2021Dec 31, 2021279+20.8%Form 10-K (filed 2024-02-14) ↗
FY2020Dec 31, 2020231+5.0%Form 10-K (filed 2023-02-09) ↗
FY2019Dec 31, 2019220+27.2%Form 10-K (filed 2022-02-16) ↗
FY2018Dec 31, 2018173-11.7%Form 10-K (filed 2021-02-09) ↗
FY2017Dec 31, 2017196+12.6%Form 10-K (filed 2019-02-13) ↗
FY2016Dec 31, 2016174–Form 10-K (filed 2019-02-13) ↗

Breakdown

What makes up defined contribution employee benefit plans — total company expense (10-k) ($m)

Cite this data

StockData. (2026). Amgen Defined Contribution Employee Benefit Plans — Total Company Expense (10-K) ($M) ($M), annual FY2016–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/dc_plan_cost

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.